Cerus Corp.
(NASDAQ : CERS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
0.72%148.250.7%$1026.38m
MDTMedtronic Plc
0.81%113.110.6%$495.86m
ABTAbbott Laboratories
0.27%85.470.8%$370.08m
TMOThermo Fisher Scientific, Inc.
1.28%320.051.0%$358.51m
ISRGIntuitive Surgical, Inc.
0.82%585.572.4%$318.70m
BDXBecton, Dickinson & Co.
0.68%260.671.1%$311.81m
DXCMDexCom, Inc.
-0.90%224.768.3%$300.02m
SYKStryker Corp.
0.40%204.021.3%$256.03m
EWEdwards Lifesciences Corp.
-1.67%238.901.2%$245.61m
BSXBoston Scientific Corp.
1.90%44.081.1%$234.11m
BAXBaxter International, Inc.
0.88%83.211.8%$208.89m
PODDInsulet Corp.
-0.15%183.966.7%$176.56m
MTDMettler-Toledo International, Inc.
3.34%761.435.4%$168.33m
HOLXHologic, Inc.
0.88%52.741.7%$160.98m
ALGNAlign Technology, Inc.
0.43%275.726.4%$153.84m

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The company produces blood system for platelets and plasma. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.